In fact, there is another project in the Desci track alongside bio, called ResearchHub (token code RSC). Compared to the bleak profitability of BIO, RSC's profit expectations are clear and bright, as its operating model is decentralized academic paper publishing. Paper publishing is an indispensable part of the scientific community, but the monopolistic and exorbitant profits of publishers have caused great suffering for researchers. The criticism of Zhihu in the Chinese public opinion sphere two years ago is still fresh in our minds, yet even after being criticized by the national team, CNKI's revenue still reached 497 million RMB in 2023. In the Western academic publishing industry, publishers have fully demonstrated the spirit of capitalism. For example, Elsevier, a global leader in scientific and medical information services, was founded in 1880 and is currently a brand under the RELX Group. Elsevier has more than 2,800 academic journals, including The Lancet and Cell, and the world's largest abstract and citation database, Scopus. In 2023, its revenue grew by 4% year-on-year to 3.88 billion USD. Profit increased by 4% year-on-year to 1.165 billion USD (based on an exchange rate of 1:1.27 GBP to USD), with a profit margin of 30%. Although it cannot be compared with the Fortune 500, once a monopoly is established, it guarantees steady income. It has been 144 years since 1880, and as long as you are still engaged in academia, with universities and research institutes, you have to honestly pay up.

Therefore, if RSC can succeed, it will definitely be a solid golden rice bowl. It will also be a great achievement for the scientific community. The scientific community has suffered long enough from publishers.